Tevogen Bio Holdings (TVGN) Invested Capital (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Invested Capital of -$9.8 million for Q1 2026, down 27.49% on a YoY basis from -$13.6 million in Q1 2025, and down 19.52% quarter-over-quarter from -$8.2 million in Q4 2025.
Tevogen Bio Holdings (TVGN) Invested Capital (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Invested Capital for 6 years, with the latest figure at -$9.8 million in Q1 2026.
- For the quarter ending Q1 2026, Invested Capital fell 27.49% year-over-year to -$9.8 million; the trailing twelve-month figure through Mar 2026 stood at -$9.8 million (down 27.49% YoY), and the FY2025 full-year result was -$8.2 million, down 23.39% from the prior year.
- Invested Capital for Q1 2026 stood at -$9.8 million, down from -$8.2 million in the prior quarter.
- The five-year high for Invested Capital was -$5.2 million in Q3 2024, with the low at -$94.4 million in Q4 2023.
- Historically, Invested Capital has averaged -$28.4 million across 5 years, with a median of -$9.8 million in 2026.
- Annual changes were most pronounced in 2023 — Invested Capital slumped 519.45% — and 2024, when it jumped 94.3%.
- Tevogen Bio Holdings' Invested Capital stood at -$34.0 million in 2022, then slumped by 178.13% to -$94.4 million in 2023, then soared by 92.93% to -$6.7 million in 2024, then decreased by 23.39% to -$8.2 million in 2025, then declined by 19.52% to -$9.8 million in 2026.
- The last three Invested Capital figures came in at -$9.8 million (Q1 2026), -$8.2 million (Q4 2025), and -$7.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 502.95 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -9.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.84 Mn |
| Dec 31, 2025 | -8.23 Mn |
| Sep 30, 2025 | -7.82 Mn |
| Jun 30, 2025 | -9.48 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -6.67 Mn |
| Sep 30, 2024 | -5.18 Mn |
| Jun 30, 2024 | -7.66 Mn |
| Mar 31, 2024 | -5.80 Mn |
| Dec 31, 2023 | -94.43 Mn |
| Sep 30, 2023 | -90.80 Mn |
| Jun 30, 2023 | -86.89 Mn |
| Mar 31, 2023 | -64.71 Mn |
| Dec 31, 2022 | -33.95 Mn |
| Sep 30, 2022 | -14.66 Mn |
| Jun 30, 2022 | -14.05 Mn |
| Mar 31, 2022 | -14.25 Mn |
| Dec 31, 2021 | -14.23 Mn |